Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Thyroid Neoplasms 1Stomach Neoplasms 1Malignant Neoplasms of Male Genital Organs 1Lymphoma, Follicular 1Goiter 1Carcinoma, Renal Cell 1Agnosia 1

Interventions

Ketamine 3Sodium Chloride 2Ropivacaine 2Propofol 2Analgesics, Opioid 2Analgesia, Patient-Controlled 2parecoxib 1Tea 1Tapentadol 1Surveys and Questionnaires 1Sevoflurane 1Saline Solution 1Lidocaine 1Ketorolac 1Ibuprofen 1Epinephrine 1Dexamethasone 1Codeine 1Clonidine 1Circumcision, Male 1Celecoxib 1Anesthesia, General 1Acupuncture Therapy 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Agnosia × Epinephrine × Clear all
NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting
170 enrolled
Genitourinary

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡